We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
677

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGTAU
4526
DELISTED
Inception Growth Acquisition Limited Unit
IGTAU
$11K ﹤0.01%
+1,120
New +$11.3K
IHC
4527
DELISTED
Independence Holding Company
IHC
$11K ﹤0.01%
195
+93
+91% +$4.96K
ADAG
4528
Adagene
ADAG
$246M
$10K ﹤0.01%
+1,278
New +$13.1K
LONA
4529
LeonaBio Inc
LONA
$75.2M
$10K ﹤0.01%
75
-271
-78% -$34.3K
BASE
4530
DELISTED
Couchbase
BASE
$10K ﹤0.01%
389
-76
-16% -$2.51K
BBAR icon
4531
BBVA Argentina
BBAR
$3.14B
$10K ﹤0.01%
3,093
+1,088
+54% +$3.85K
BBIN icon
4532
JPMorgan BetaBuilders International Equity ETF
BBIN
$6.59B
$10K ﹤0.01%
+168
New +$10K
BZFD icon
4533
BuzzFeed
BZFD
$90.8M
$10K ﹤0.01%
454
+63
+16% +$2.22K
CATO icon
4534
Cato Corp
CATO
$67.5M
$10K ﹤0.01%
576
-118
-17% -$2.03K
CDRE icon
4535
Cadre Holdings
CDRE
$1.46B
$10K ﹤0.01%
+391
New +$7.93K
CHRD icon
4536
Chord Energy
CHRD
$7.56B
$10K ﹤0.01%
76
-2,348
-97% -$279K
CIA icon
4537
Citizens
CIA
$200M
$10K ﹤0.01%
1,924
+549
+40% +$3.36K
CMPX icon
4538
Compass Therapeutics
CMPX
$403M
$10K ﹤0.01%
+3,205
New +$10.6K
CNSP icon
4539
CNS Pharmaceuticals
CNSP
$7.99M
0
CNTA
4540
DELISTED
Centessa Pharmaceuticals
CNTA
$10K ﹤0.01%
930
+811
+682% +$10.9K
CPF icon
4541
Central Pacific Financial
CPF
$998M
$10K ﹤0.01%
359
-1,788
-83% -$48.9K
CRMT icon
4542
America's Car Mart
CRMT
$25.8M
$10K ﹤0.01%
102
+40
+65% +$4.51K
CSPI icon
4543
CSP Inc
CSPI
$79.1M
$10K ﹤0.01%
2,280
+1,914
+523% +$8.27K
CVR icon
4544
Chicago Rivet & Machine Co
CVR
$9.98M
$10K ﹤0.01%
367
+183
+99% +$4.82K
CVV icon
4545
CVD Equipment Corp
CVV
$57.9M
$10K ﹤0.01%
2,388
+1,097
+85% +$5.1K
DAC icon
4546
Danaos Corp
DAC
$2.58B
$10K ﹤0.01%
+129
New +$9.31K
DEM icon
4547
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
$10K ﹤0.01%
224
-300
-57% -$13.1K
DFE icon
4548
WisdomTree Europe SmallCap Dividend Fund
DFE
$170M
$10K ﹤0.01%
134
DGICA icon
4549
Donegal Group Class A
DGICA
$693M
$10K ﹤0.01%
723
-4,744
-87% -$68K
DNA icon
4550
Ginkgo Bioworks
DNA
$458M
$10K ﹤0.01%
31
+13
+72% +$6.17K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 677 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.